Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 59

1.

Effect of collagen turnover and matrix metalloproteinase activity on healing of venous leg ulcers.

Meyer FJ, Burnand KG, Abisi S, Tekoppele JM, van Els B, Smith A.

Br J Surg. 2008 Mar;95(3):319-25.

PMID:
17854113
2.

MMP protein and activity levels in synovial fluid from patients with joint injury, inflammatory arthritis, and osteoarthritis.

Tchetverikov I, Lohmander LS, Verzijl N, Huizinga TW, TeKoppele JM, Hanemaaijer R, DeGroot J.

Ann Rheum Dis. 2005 May;64(5):694-8.

3.

MMP profile in paired serum and synovial fluid samples of patients with rheumatoid arthritis.

Tchetverikov I, Ronday HK, Van El B, Kiers GH, Verzijl N, TeKoppele JM, Huizinga TW, DeGroot J, Hanemaaijer R.

Ann Rheum Dis. 2004 Jul;63(7):881-3.

4.

Accumulation of advanced glycation end products as a molecular mechanism for aging as a risk factor in osteoarthritis.

DeGroot J, Verzijl N, Wenting-van Wijk MJ, Jacobs KM, Van El B, Van Roermund PM, Bank RA, Bijlsma JW, TeKoppele JM, Lafeber FP.

Arthritis Rheum. 2004 Apr;50(4):1207-15.

5.

Active MMPs captured by alpha 2 macroglobulin as a marker of disease activity in rheumatoid arthritis.

Tchetverikov I, Verzijl N, Huizinga TW, TeKoppele JM, Hanemaaijer R, DeGroot J.

Clin Exp Rheumatol. 2003 Nov-Dec;21(6):711-8.

PMID:
14740449
6.

Advanced glycation end product ligands for the receptor for advanced glycation end products: biochemical characterization and formation kinetics.

Valencia JV, Weldon SC, Quinn D, Kiers GH, DeGroot J, TeKoppele JM, Hughes TE.

Anal Biochem. 2004 Jan 1;324(1):68-78.

PMID:
14654047
7.

Matrix metalloproteinases-3, -8, -9 as markers of disease activity and joint damage progression in early rheumatoid arthritis.

Tchetverikov I, Lard LR, DeGroot J, Verzijl N, TeKoppele JM, Breedveld FC, Huizinga TW, Hanemaaijer R.

Ann Rheum Dis. 2003 Nov;62(11):1094-9.

8.

AGEing and osteoarthritis: a different perspective.

Verzijl N, Bank RA, TeKoppele JM, DeGroot J.

Curr Opin Rheumatol. 2003 Sep;15(5):616-22. Review.

PMID:
12960490
9.

Extracellular mitochondrial DNA and oxidatively damaged DNA in synovial fluid of patients with rheumatoid arthritis.

Hajizadeh S, DeGroot J, TeKoppele JM, Tarkowski A, Collins LV.

Arthritis Res Ther. 2003;5(5):R234-40. Epub 2003 Jun 25.

10.

Identification of PLOD2 as telopeptide lysyl hydroxylase, an important enzyme in fibrosis.

van der Slot AJ, Zuurmond AM, Bardoel AF, Wijmenga C, Pruijs HE, Sillence DO, Brinckmann J, Abraham DJ, Black CM, Verzijl N, DeGroot J, Hanemaaijer R, TeKoppele JM, Huizinga TW, Bank RA.

J Biol Chem. 2003 Oct 17;278(42):40967-72. Epub 2003 Jul 24.

11.

No therapeutic effect of plasmin antagonist tranexamic acid in rheumatoid arthritis. A double-blind placebo-controlled pilot study.

van der Laan WH, Ronday HK, TeKoppele JM, Breedveld FC, Huizinga TW, Verheijen JH.

Clin Exp Rheumatol. 2003 May-Jun;21(3):359-62.

PMID:
12846058
12.

Identification of disease- and nutrient-related metabolic fingerprints in osteoarthritic Guinea pigs.

Lamers RJ, DeGroot J, Spies-Faber EJ, Jellema RH, Kraus VB, Verzijl N, TeKoppele JM, Spijksma GK, Vogels JT, van der Greef J, van Nesselrooij JH.

J Nutr. 2003 Jun;133(6):1776-80.

13.

Induction of advanced glycation end products and alterations of the tensile properties of articular cartilage.

Chen AC, Temple MM, Ng DM, Verzijl N, DeGroot J, TeKoppele JM, Sah RL.

Arthritis Rheum. 2002 Dec;46(12):3212-7.

14.

A comparative analysis of bone and cartilage metabolism in two strains of guinea-pig with varying degrees of naturally occurring osteoarthritis.

Huebner JL, Hanes MA, Beekman B, TeKoppele JM, Kraus VB.

Osteoarthritis Cartilage. 2002 Oct;10(10):758-67.

15.

Molecular markers for osteoarthritis: the road ahead.

DeGroot J, Bank RA, Tchetverikov I, Verzijl N, TeKoppele JM.

Curr Opin Rheumatol. 2002 Sep;14(5):585-9. Review.

PMID:
12192260
16.

Development of biochemical heterogeneity of articular cartilage: influences of age and exercise.

Brama PA, TeKoppele JM, Bank RA, Barneveld A, van Weeren PR.

Equine Vet J. 2002 May;34(3):265-9.

PMID:
12108744
17.

Steady progression of osteoarthritic features in the canine groove model.

Marijnissen AC, van Roermund PM, Verzijl N, Tekoppele JM, Bijlsma JW, Lafeber FP.

Osteoarthritis Cartilage. 2002 Apr;10(4):282-9.

18.

Biochemical development of subchondral bone from birth until age eleven months and the influence of physical activity.

Brama PA, TeKoppele JM, Bank RA, Barneveld A, van Weeren PR.

Equine Vet J. 2002 Mar;34(2):143-9.

PMID:
11905435
19.

The canine 'groove' model, compared with the ACLT model of osteoarthritis.

Marijnissen AC, van Roermund PM, TeKoppele JM, Bijlsma JW, Lafeber FP.

Osteoarthritis Cartilage. 2002 Feb;10(2):145-55.

20.

Putative role of lysyl hydroxylation and pyridinoline cross-linking during adolescence in the occurrence of osteoarthritis at old age.

Bank RA, Verzijl N, Lafeber FP, Tekoppele JM.

Osteoarthritis Cartilage. 2002 Feb;10(2):127-34.

Supplemental Content

Loading ...
Support Center